Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $4.8950 (-5.96%) ($4.8950 - $4.8950) on Wed. Jan. 5, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.98% (three month average) | RSI | 35 | Latest Price | $4.8950(-5.96%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.8% a day on average for past five trading days. | Weekly Trend | AUTL declines -2.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) XBI(66%) IBB(60%) IBUY(59%) ARKG(56%) ARKK(55%) | Factors Impacting AUTL price | AUTL will decline at least -2.49% in a week (0% probabilities). VIXM(-40%) VXX(-32%) TLT(-24%) SHY(-22%) TIP(-18%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.49% (StdDev 4.98%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.6(-377.83%) | Resistance Level | $5.56 | 5 Day Moving Average | $5.22(-6.23%) | 10 Day Moving Average | $5.24(-6.58%) | 20 Day Moving Average | $5.56(-11.96%) | To recent high | -30.5% | To recent low | 0% | Market Cap | $256m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |